Key facts
- WinDigital Capital Management is a other based in Beijing, China with 5 tracked portfolio companies.
- Notable positions include Immunofoco Biotechnology, Atmen Pharmaceutical, GeekGene, Celgenyx, Oralead Pharma.
About WinDigital Capital Management
WinDigital Capital Management is a private investment fund based in Beijing, China. Established in 2016, WinDigital Capital is a private equity investment fund focusing on China. It integrates domestic and overseas resources to actively lay out equity investments in emerging industries, focusing on life sciences, biomedical, TMT, and core hard technology sectors. The assets are managed by the executive management team.
Free account
See the whole book
- ·Watchlist + alerts for WinDigital Capital Management's activity
Create free account
No card required
Portfolio, priced
5 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Immunofoco Biotechnology | — | $298.1M | — | |
| Atmen Pharmaceutical | — | $225.4M | — | |
| GeekGene | — | $66.7M | — | |
| Celgenyx | — | — | — | |
| Oralead Pharma | — | — | — |
Frequently asked
- What companies does WinDigital Capital Management invest in?
- WinDigital Capital Management has 5 recorded portfolio companies, including Immunofoco Biotechnology, Atmen Pharmaceutical, GeekGene, Celgenyx.